- Home
- CBUS vs DHY Comparison
CBUS vs DHY Comparison
Compare CBUS & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBUS | DHY |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.7M | 208.3M |
| IPO Year | 2017 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CBUS | DHY |
|---|---|---|
| Price | $1.92 | $1.89 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 628.5K | 527.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $126.00 | N/A |
| Revenue Next Year | $110.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $1.82 |
| 52 Week High | $4.19 | $2.16 |
Technical Indicators
Market Signals| Indicator | CBUS | DHY |
|---|---|---|
| Relative Strength Index (RSI) | 35.68 | 49.02 |
| Support Level | $1.31 | $1.84 |
| Resistance Level | $2.48 | $2.14 |
| Average True Range (ATR) | 0.34 | 0.03 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 11.34 | 81.25 |
Price Performance
Historical ComparisonAbout CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.